/ LLY
/ Market Analysis
Why Is Eli Lilly (LLY) Stock Up Premarket? $2.4B Biotech Acquisition
Eli Lilly shares rose in premarket trading after the company announced a $2.4 billion deal to acquire Orna Therapeutics.
February 09, 2026
Q4 Earnings Summary: Eli Lilly and AbbVie Beat, Uber Mixed
Quarterly earnings reveal a mix of positive surprises and challenges, with Eli Lilly and AbbVie beating expectations and Uber facing hurdles.
February 04, 2026
Why Did Eli Lilly (LLY) Shares Surge Today? Key Factors
Eli Lilly shares surged over 4.5% on analyst upgrades, acquisition rumors involving Ventyx Biosciences, and a new $1.3 billion research partnership.
January 07, 2026
Eli Lilly Breaks $1 Trillion Barrier, a First for the Healthcare Industry
Eli Lilly hit a $1 trillion valuation for the first time, becoming the only healthcare company to reach the milestone as demand for its weight-loss drugs continues to surge.
November 21, 2025
Eli Lilly Delivers Strong Q3 Performance, Raises Earnings Outlook
Eli Lilly’s Q3 2025 revenue jumped 54% to $17.6 billion with adjusted EPS of $7.02, prompting the company to lift its full-year guidance.
October 30, 2025More from The Tokenist / LLY
Eli Lilly’s Q4 2024 Revenue Surges by 45% to $13.53 Billion
February 06, 2025
Back to 
